These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 31894538)

  • 61. Impacts of Rho kinase inhibitor Fasudil on Rho/ROCK signaling pathway in rabbits with optic nerve injury.
    Yu J; Lin L; Luan X; Jing X; Maierab
    Int J Clin Exp Pathol; 2015; 8(11):14717-24. PubMed ID: 26823796
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Chronic Rho-kinase inhibition improves left ventricular contractile dysfunction in early type-1 diabetes by increasing myosin cross-bridge extension.
    Waddingham MT; Edgley AJ; Astolfo A; Inagaki T; Fujii Y; Du CK; Zhan DY; Tsuchimochi H; Yagi N; Kelly DJ; Shirai M; Pearson JT
    Cardiovasc Diabetol; 2015 Jul; 14():92. PubMed ID: 26194354
    [TBL] [Abstract][Full Text] [Related]  

  • 63. ROCK inhibitor fasudil attenuated high glucose-induced MCP-1 and VCAM-1 expression and monocyte-endothelial cell adhesion.
    Li H; Peng W; Jian W; Li Y; Li Q; Li W; Xu Y
    Cardiovasc Diabetol; 2012 Jun; 11():65. PubMed ID: 22694757
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Chronic treatment with an oral rho-kinase inhibitor restores erectile function by suppressing corporal apoptosis in diabetic rats.
    Li WJ; Park K; Paick JS; Kim SW
    J Sex Med; 2011 Feb; 8(2):400-10. PubMed ID: 20233282
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Involvement of Rho-kinase in collar-induced vasoconstriction and vascular hypersensitivity to serotonin in rat carotid.
    Xie L; Zeng D; Zhang H; Sun D; Pang X; Guan Q
    Int J Cardiol; 2011 Apr; 148(2):168-73. PubMed ID: 19942308
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Role of Rho Kinase Inhibition in the Protective Effect of Fasudil and Simvastatin Against 3-Nitropropionic Acid-Induced Striatal Neurodegeneration and Mitochondrial Dysfunction in Rats.
    Ahmed LA; Darwish HA; Abdelsalam RM; Amin HA
    Mol Neurobiol; 2016 Aug; 53(6):3927-3938. PubMed ID: 26169112
    [TBL] [Abstract][Full Text] [Related]  

  • 67. RhoA/ROCK pathway inhibition by fasudil suppresses the vasculogenic mimicry of U2OS osteosarcoma cells in vitro.
    Xia Y; Cai X; Fan J; Zhang L; Li Z; Ren J; Wu G; Zhu F
    Anticancer Drugs; 2017 Jun; 28(5):514-521. PubMed ID: 28225457
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fasudil suppresses fibrosarcoma growth by stimulating secretion of the chemokine CXCL14/BRAK.
    Miyamoto C; Maehata Y; Ozawa S; Ikoma T; Kubota E; Izukuri K; Kato Y; Hata R; Lee MC
    J Pharmacol Sci; 2012; 120(3):241-9. PubMed ID: 23099322
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Fasudil, a Rho-Associated Coiled Coil-Forming Protein Kinase Inhibitor, Recovers Methylmercury-Induced Axonal Degeneration by Changing Microglial Phenotype in Rats.
    Fujimura M; Usuki F; Nakamura A
    Toxicol Sci; 2019 Mar; 168(1):126-136. PubMed ID: 30462329
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Fasudil alleviates pressure overload-induced heart failure by activating Nrf2-mediated antioxidant responses.
    Guan P; Liang Y; Wang N
    J Cell Biochem; 2018 Aug; 119(8):6452-6460. PubMed ID: 29323739
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Rho-kinase inhibition improves vasodilator responsiveness during hyperinsulinemia in the metabolic syndrome.
    Schinzari F; Tesauro M; Rovella V; Di Daniele N; Gentileschi P; Mores N; Campia U; Cardillo C
    Am J Physiol Endocrinol Metab; 2012 Sep; 303(6):E806-11. PubMed ID: 22829585
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Protective Effect of RIVA Against Sunitinib-Induced Cardiotoxicity by Inhibiting Oxidative Stress-Mediated Inflammation: Probable Role of TGF-β and Smad Signaling.
    Imam F; Al-Harbi NO; Khan MR; Qamar W; Alharbi M; Alshamrani AA; Alhamami HN; Alsaleh NB; Alharbi KS
    Cardiovasc Toxicol; 2020 Jun; 20(3):281-290. PubMed ID: 31696377
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Fasudil attenuates oxidative stress-induced partial epithelial-mesenchymal transition of tubular epithelial cells in hyperuricemic nephropathy via activating Nrf2.
    Cao Y; Wang Y; Li W; Feng J; Chen Y; Chen R; Hu L; Wei J
    Eur J Pharmacol; 2024 Jul; 975():176640. PubMed ID: 38750716
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control.
    Kolavennu V; Zeng L; Peng H; Wang Y; Danesh FR
    Diabetes; 2008 Mar; 57(3):714-23. PubMed ID: 18083785
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Effects of the Rho-kinase inhibitor fasudil on the invasion, migration, and apoptosis of human prostate cancer PC3 and DU145 cells].
    Gao QQ; Chen H; Chen Y; Xu ZP; Zhu LL; Yu W; Han YF; Dai YT
    Zhonghua Nan Ke Xue; 2016 Jun; 22(6):483-490. PubMed ID: 28963834
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Role of Rho kinase and oxidative stress in cardiac fibrosis induced by aldosterone and salt in angiotensin type 1a receptor knockout mice.
    Kagiyama S; Matsumura K; Goto K; Otsubo T; Iida M
    Regul Pept; 2010 Feb; 160(1-3):133-9. PubMed ID: 19969025
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Protective effect of fasudil, a Rho-kinase inhibitor, on chemokine expression, leukocyte recruitment, and hepatocellular apoptosis in septic liver injury.
    Thorlacius K; Slotta JE; Laschke MW; Wang Y; Menger MD; Jeppsson B; Thorlacius H
    J Leukoc Biol; 2006 May; 79(5):923-31. PubMed ID: 16641138
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Role of the RhoA/ROCK pathway in high-altitude associated neonatal pulmonary hypertension in lambs.
    Lopez NC; Ebensperger G; Herrera EA; Reyes RV; Calaf G; Cabello G; Moraga FA; Beñaldo FA; Diaz M; Parer JT; Llanos AJ
    Am J Physiol Regul Integr Comp Physiol; 2016 Jun; 310(11):R1053-63. PubMed ID: 26911462
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Inhibition of the Rho/ROCK pathway enhances the efficacy of cisplatin through the blockage of hypoxia-inducible factor-1α in human ovarian cancer cells.
    Ohta T; Takahashi T; Shibuya T; Amita M; Henmi N; Takahashi K; Kurachi H
    Cancer Biol Ther; 2012 Jan; 13(1):25-33. PubMed ID: 22336585
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Spironolactone Attenuates Doxorubicin-induced Cardiotoxicity in Rats.
    Liu G; Liu Y; Wang R; Hou T; Chen C; Zheng S; Dong Z
    Cardiovasc Ther; 2016 Aug; 34(4):216-24. PubMed ID: 27097055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.